InvestorsHub Logo
Followers 38
Posts 2285
Boards Moderated 0
Alias Born 12/23/2011

Re: None

Monday, 03/16/2015 11:25:33 AM

Monday, March 16, 2015 11:25:33 AM

Post# of 108192
"Though preliminary, the data we have observed thus far are extremely encouraging as all treated patients enrolled since April 2013 have had a complete response with no recurrence of the cancer."
-www.globenewswire.com/news-release/2015/03/16/715423/10124782/en/Advaxis-Presents-Preliminary-Data-From-a-Phase-1-2-Trial-of-ADXS-HPV-in-HPV-Associated-Anal-Cancer-in-Combination-With-Chemoradiation-Showing-Complete-Response-and-No-Recurrences-t.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News